The independent risk factors for HCC recurrence in our study were AFP >400 ng/mL, moderate/poor differentiated tumor, and microvascular invasion, that should be considered in selecting patients with HCC for liver transplantation, and also need close follow up for early detection of any tumor recurrence. The gene discussed is AFP; the disease is hepatocellular carcinoma.